You just read:

Zebinix® (eslicarbazepine acetate) Receives Positive CHMP Opinion as Once-daily Monotherapy for Newly Diagnosed Focal-onset Epilepsy

News provided by

Eisai

28 Mar, 2017, 00:01 BST